A sequential approach to the treatment of muscle invasive, non-metastatic urothelial carcinoma of the bladder: a phase II trial of neoadjuvant gemcitabine, paclitaxel and carboplatin with molecular correlates.
Phase of Trial: Phase II
Latest Information Update: 24 May 2013
At a glance
- Drugs Carboplatin; Gemcitabine; Paclitaxel
- Indications Bladder cancer; Urogenital cancer
- Focus Biomarker; Therapeutic Use
- 19 Jan 2007 Status changed from recruiting
- 05 Aug 2005 New trial record.